DSpace at RU >

Search Results

Results 1-50 of 206.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2011	De apotheker draait door	Burger, David
	2011	Interaction between antiretroviral drugs and acenocoumarol	Welzen, M.E.B.; Berk, G.E. van den; Hamers, R.L.; Burger, D.M.
	2011	Selection of an M184V mutation in the cerebrospinal fluid of a treatment-naive HIV-infected individual starting darunavir-based therapy	Cornelissen, M.; Back, N.K.; Burger, D.M.; Blom, P.; Portegies, P.; Prins, J.M.; Valk, M. van der
	2011	Rhabdomyolysis in an HIV-infected patient with impaired renal function concomitantly treated with rosuvastatin and lopinavir/ritonavir	Kanter, C.T.M.M. de; Keuter, M.; Lee, M.J. van der; Koopmans, P.P.; Burger, D.M.
	2011	A twice daily posaconazole dosing algorithm for children with chronic granulomatous disease	Welzen, M.E.B.; Bruggemann, R.J.M.; Berg, J.M. van den; Voogt, H.W.; Gilissen, J.H.; Pajkrt, D.; Klein, N.; Burger, D.M.; Warris, A.
	2011	Adherence to HIV therapeutic drug monitoring guidelines in The Netherlands	Luin, M. van; Wit, F.W.; Smit, C.; Rigter, I.M.; Franssen, E.J.; Richter, C.; Kroon, F.; Wolf, F. de; Burger, D.M.
	2011	Impact of therapeutic drug monitoring of voriconazole in a pediatric population	Bruggemann, R.J.M.; Linden, J.W.M. van der; Verweij, P.E.; Burger, D.M.; Warris, A.
	2011	Ribavirin plasma concentration measurements in patients with hepatitis C: early ribavirin concentrations predict steady-state concentrations	Slavenburg, S.; Huntjens-Fleuren, H.W.; Dofferhoff, T.S.; Richter, C.; Koopmans, P.P.; Verwey-van Wissen, C.P.W.G.M.; Drenth, J.P.H.; Burger, D.M.
	2011	The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus	Dekker, D.; Dorresteijn, M.J.; Pijnenburg, M.; Heemskerk, S.; Rasing-Hoogveld, A.; Burger, D.M.; Wagener, F.A.D.T.G.; Smits, P.
	2011	The International Interlaboratory Quality Control Program for Measurement of Antiretroviral Drugs in Plasma: a global proficiency testing program.	Burger, D.M.; Teulen, M.J.A.; Eerland, J.; Harteveld, A.; Aarnoutse, R.E.; Touw, D.
	2011	Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children.	Bunupuradah, T.; Kosalaraksa, P.; Puthanakit, T.; Mengthaisong, T.; Wongsabut, J.; Lumbiganon, P.; Phanuphak, P.; Burger, D.M.; Pancharoen, C.; Ananworanich, J.
	2011	Paediatric drug development: are population models predictive of pharmacokinetics across paediatric populations?	Cella, M.; Zhao, W.; Jacqz-Aigrain, E.; Burger, D.M.; Danhof, M.; Pasqua, O. Della
	2011	The lopinavir/ritonavir-associated rise in lipids is not related to lopinavir or ritonavir plasma concentration	Bierman, W.F.; Vonderen, M.G. van; Veldkamp, A.I.; Burger, D.M.; Danner, S.A.; Reiss, P.; Agtmael, M.A. van
	2011	Pediatric underdosing of efavirenz: a pharmacokinetic study in Uganda	Fillekes, Q.; Natukunda, E.; Balungi, J.; Kendall, L.; Bwakura-Dangarembizi, M.; Keishanyu, R.; Ferrier, A.; Lutakome, J.; Gibb, D.M.; Burger, D.M.; Walker, A.S.
	2011	Thai HIV-1-infected women do not require a dose increase of lopinavir/ritonavir during the third trimester of pregnancy.	Ramautarsing, R.A.; Lugt, J. van der; Gorowara, M.; Kerr, S.J.; Burger, D.M.; Ruxrungtham, K.; Phanuphak, P.; Chaithongwongwatthana, S.; Avihingsanon, A.; Phanuphak, N.
	2010	Suboptimal endogenous erythropoietin response in chronic hepatitis C patients during ribavirin and PEG interferon treatment	Vlerken, L. van; Soest, H. van; Janssen, M.P.; Boland, G.J.; Drenth, J.P.H.; Burger, D.M.; Siersema, P.D.; Erpecum, K.J. van
	2010	Pharmacokinetics of double-dose raltegravir in two patients with HIV infection and tuberculosis.	Burger, D.M.; Magis-Escurra Ibanez, C.; Berk, G.E. van den; Gelinck, L.B.S.
	2010	Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-<36 months.	Jacqz-Aigrain, E.; Harrison, L.; Zhao, W.; Compagnucci, A.; Castro, H.; Farrelly, L.; Saidi, Y.; Hamadache, D.; Welch, S.; Wintergerst, U.; Forcat, S.; Hadjou, G.; Firtion, G.; Snowden, W.; Giaquinto, C.; Gibb, D.; Burger, D.M.; Aboulker, J.P.; Brothers, C.
	2010	No changes in efavirenz plasma concentrations in HIV-infected patients who switch from Stocrin to Atripla.	Burger, D.M.; Luin, M. van; Bosch, M.; Ven, A.J.A.M. van der; Brouwer, A.M.; Keuter, M.; Dofferhoff, T.; Koopmans, P.P.
	2010	The role of therapeutic drug monitoring in pediatric HIV/AIDS.	Burger, D.M.
	2010	Raltegravir: a review of its pharmacokinetics, pharmacology and clinical studies.	Burger, D.M.
	2010	A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancer.	Desar, I.M.E.; Timmer-Bonte, J.N.H.; Burger, D.M.; Graaf, W.T.A. van der; Herpen, C.M.L. van
	2010	Pharmacokinetics of low-dose protease inhibitors and efavirenz in low- and middle-income countries.	Gorowara, M.; Burger, D.M.; Hill, A.; Ruxrungtham, K.
	2010	Effect of posaconazole on the pharmacokinetics of fosamprenavir and vice versa in healthy volunteers.	Bruggemann, R.J.M.; Luin, M. van; Colbers, E.P.H.; Dungen, M.W. van den; Pharo, C.; Schouwenberg, B.J.J.W.; Burger, D.M.
	2010	Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir.	Luin, M. van; Ende, M.E. van der; Richter, C.; Visser, M. de; Faraj, D.; Ven, A.J.A.M. van der; Gelinck, L.; Kroon, F.; Wit, F.W.; Schaik, R.H. van; Kuks, P.F.M.; Burger, D.M.
	2010	A model-based approach to dose selection in early pediatric development.	Cella, M.; Gorter de Vries, F.; Burger, D.M.; Danhof, M.; Pasqua, O. Della
	2010	Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients.	Bruggemann, R.J.M.; Blijlevens, N.M.A.; Burger, D.M.; Franke, B.; Troke, P.F.; Donnelly, J.P.
	2010	Drug-drug interactions between raltegravir and pravastatin in healthy volunteers.	Luin, M. van; Colbers, A.; Ewijk-Beneken Kolmer, E.W.J. van; Verwey-van Wissen, C.P.W.G.M.; Schouwenberg, B.J.J.W.; Hoitsma, A.J.; Silva, H.G. da; Burger, D.M.
	2010	Ultra-fast analysis of plasma and intracellular levels of HIV protease inhibitors in children: a clinical application of MALDI mass spectrometry.	Kampen, J.J. van; Reedijk, M.L.; Burgers, P.C.; Dekker, L.J.; Hartwig, N.G.; Ende, I.E. van der; Groot, R. de; Osterhaus, A.D.; Burger, D.M.; Luider, T.M.; Gruters, R.A.
	2010	Suboptimal endogenous erythropoietin response in chronic hepatitis C patients during ribavirin and PEG interferon treatment.	Vlerken, L.G. Van; Soest, H. van; Janssen, M.P.E.; Boland, G.J.; Drenth, J.P.H.; Burger, D.M.; Siersema, P.D.; Erpecum, K.J. van
	2010	Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium.	Montezano, A.C.; Zimmerman, D.; Yusuf, H.; Burger, D.M.; Chignalia, A.Z.; Wadhera, V.; Leeuwen, F.N. van; Touyz, R.M.
	2010	Ultrafast and high-throughput mass spectrometric assay for therapeutic drug monitoring of antiretroviral drugs in pediatric HIV-1 infection applying dried blood spots.	Meesters, R.J.; Kampen, J.J. van; Reedijk, M.L.; Scheuer, R.D.; Dekker, L.J.; Burger, D.M.; Hartwig, N.G.; Osterhaus, A.D.; Luider, T.M.; Gruters, R.A.
	2010	Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial.	Musiime, V.; Kendall, L.; Bakeera-Kitaka, S.; Snowden, W.B.; Odongo, F.; Thomason, M.; Musoke, P.; Adkison, K.; Burger, D.M.; Mugyenyi, P.; Kekitiinwa, A.; Gibb, D.M.; Walker, A.S.
	2010	Limited sampling models to predict the pharmacokinetics of nevirapine, stavudine, and lamivudine in HIV-infected children treated with pediatric fixed-dose combination tablets.	Burger, D.M.; Ewings, F.; Kabamba, D.; L'homme, R.F.A.; Mulenga, V.; Kankasa, C.; Thomason, M.; Gibb, D.M.; Chintu, C.; Walker, A.S.
	2010	Steady-state nevirapine, lamivudine and stavudine levels in Malawian HIV-infected children on antiretroviral therapy using split Triomune 30 tablets.	Poerksen, G.; Pollock, L.; Moons, P.; Chesshyre, E.; Burger, D.M.; Khoo, S.; Molyneux, E.
	2010	Strategies for nevirapine initiation in HIV-infected children taking pediatric fixed-dose combination "baby pills" in Zambia: a randomized controlled trial.	Mulenga, V.; Cook, A.; Walker, A.S.; Kabamba, D.; Chijoka, C.; Ferrier, A.; Kalengo, C.; Kityo, C.; Kankasa, C.; Burger, D.M.; Thomason, M.; Chintu, C.; Gibb, D.M.
	2010	Pharmacokinetics of two generic co-formulations of lopinavir/ritonavir for HIV-infected children: a pilot study of paediatric Lopimune versus the branded product in healthy adult volunteers.	Kanter, C.T.M.M. de; Colbers, E.P.H.; Fillekes, Q.; Hoitsma, A.J.; Burger, D.M.
	2009	Drug-drug interactions with raltegravir	Burger, D.M.
	2009	Etravirine biedt hoop bij aids. Nieuw hiv-middel geeft minder bijwerkingen en resistentie.	Heide, I. van der; Burger, D.M.
	2009	Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz Discontinuations	Luin, M. van; Gras, L.; Richter, C.; Ende, M.E. van der; Prins, J.M.; Wolf, F. de; Burger, D.M.; Wit, F.W.
	2009	Pilotstudie Lopimune versus Kaletra bij gezonde vrijwilligers. Farmacokinetiek van twee generieke combinatieproducten met lopinavir en ritonavir voor hiv-geinfecteerde kinderen.	Kanter, C.T.M.M. de; Colbers, E.P.H.; Fillekes, Q.; Hoitsma, A.J.; Burger, D.M.
	2009	Severe hyponatremia caused by hyperglycaemia due to interferon alpha therapy in advanced renal cell carcinoma.	Soetekouw, P.M.M.B.; Koopman, M.; Burger, D.M.; Tjan-Heijnen, V.C.; Mulder, P.H.M. de
	2009	Pharmacokinetics of sunitinib in an obese patient with a GIST.	Desar, I.M.E.; Burger, D.M.; Hoesel, Q.G.C.M. van; Beijnen, J.H.; Herpen, C.M.L. van; Graaf, W.T.A. van der
	2009	Efavirenz dose reduction to 200 mg once daily in a patient treated with rifampicin.	Luin, M. van; Brouwer, A.E.; Ven, A.J.A.M. van der; Lange, W. de; Schaik, R.H. van; Burger, D.M.
	2009	International interlaboratory proficiency testing program for measurement of azole antifungal plasma concentrations.	Bruggemann, R.J.M.; Touw, D.J.; Aarnoutse, R.E.; Verweij, P.E.; Burger, D.M.
	2009	Clinical experience with the combined use of lopinavir/ritonavir and rifampicin.	L'homme, R.F.A.; Nijland, H.M.J.; Gras, L.; Aarnoutse, R.E.; Crevel, R. van; Boeree, M.J.; Brinkman, K.; Prins, J.M.; Juttmann, J.R.; Burger, D.M.
	2009	Reducing the boosting dose of ritonavir does not affect saquinavir plasma concentrations in HIV-1-infected individuals.	Lugt, J. van der; Gorowara, M.; Avihingsanon, A.; Burger, D.M.; Ananworanich, J.; Sringam, K.; Kerr, S.; Wit, F.; Lange, J.; Ruxrungtham, K.
	2009	Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents.	Bruggemann, R.J.M.; Alffenaar, J.W.C.; Blijlevens, N.M.A.; Billaud, E.M.; Kosterink, J.G.W.; Verweij, P.E.; Burger, D.M.
	2009	The effect of raltegravir on the glucuronidation of lamotrigine.	Luin, M. van; Colbers, A.; Verwey-van Wissen, C.P.W.G.M.; Ewijk-Beneken Kolmer, E.W.J. van; Kolk, M. van der; Hoitsma, A.J.; Silva, H.G. da; Burger, D.M.
	2009	A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adults.	Avihingsanon, A.; Lugt, J. van der; Kerr, S.J.; Gorowara, M.; Chanmano, S.; Ohata, P.; Lange, J.; Cooper, D.A.; Phanuphak, P.; Burger, D.M.; Ruxrungtham, K.

1 2 3 4 5 next